AKT1 and glioblastoma: Upon activation of the AKT/mTORC1 pathway, the fatostatin-induced decrease in the invasive capacity of GBM cells as well as the expression of EMT-related proteins (including E-cadherin, N-cadherin, snail1, and vimentin) was also reversed (Fig. 6D, E).